Chief Medical Officer & Executive Vice President of Clinical Development

• Dr. Megerian has over 20 years designing and executing clinical trials and leading clinical development programs
• From 2015 to 2017, he was Vice President of Clinical Development followed by Vice President for Medical Affairs at Avanir, building a cutting edge organization and managing a high-functioning team of 30 pharmaceutical professionals
• Prior to his role at Avanir, he was Vice President for Strategic Medical Science in the Codman Neuroscience Division of Johnson & Johnson, where he set scientific and medical strategy, managed the clinical development program and led FDA regulated clinical trials for new indications, working with the regulatory department and meeting with the FDA at various stages of approval
• Dr. Megerian ran clinical in the neurology & neuropsychiatric therapeutic arena at all stages of development as Senior Medical Director at Neurometrix (2003 to 2007) and as Executive Director of Clinical Development at Epix Pharmaceuticals (2007 – 2009)
• He trained in the Medical Scientist Training Program at Northwestern University, earning MD, PhD in Neuroscience (1993). He did his Pediatrics training at Boston City Hospital and his Neurology Training at the Harvard-Longwood Program, completing residency in 1998 and a Fellowship in Behavioral Child Neurology at Boston Children’s Hospital in 2000
• Dr. Megerian was Attending Neurologist in Behavioral Child Neurology at Boston Children’s Hospital and at MassGeneral For Children, North Shore Hospital, where he ran autism programs for Neurology and was Instructor in Neurology at Harvard University Medical School (1999-2015)
• Dr. Megerian continues to see patients a few hours each month, specializing in treating children with autism